- Home
- ACNB vs VSTM Comparison
ACNB vs VSTM Comparison
Compare ACNB & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACNB
- VSTM
- Stock Information
- Founded
- ACNB 1857
- VSTM 2010
- Country
- ACNB United States
- VSTM United States
- Employees
- ACNB N/A
- VSTM N/A
- Industry
- ACNB Major Banks
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- ACNB Finance
- VSTM Health Care
- Exchange
- ACNB Nasdaq
- VSTM Nasdaq
- Market Cap
- ACNB 432.5M
- VSTM 425.9M
- IPO Year
- ACNB N/A
- VSTM 2012
- Fundamental
- Price
- ACNB $44.04
- VSTM $4.38
- Analyst Decision
- ACNB Strong Buy
- VSTM Strong Buy
- Analyst Count
- ACNB 4
- VSTM 9
- Target Price
- ACNB $50.00
- VSTM $12.63
- AVG Volume (30 Days)
- ACNB 37.3K
- VSTM 2.6M
- Earning Date
- ACNB 07-23-2025
- VSTM 08-07-2025
- Dividend Yield
- ACNB 3.16%
- VSTM N/A
- EPS Growth
- ACNB N/A
- VSTM N/A
- EPS
- ACNB 2.79
- VSTM N/A
- Revenue
- ACNB $113,448,000.00
- VSTM $10,000,000.00
- Revenue This Year
- ACNB $38.67
- VSTM $129.06
- Revenue Next Year
- ACNB $5.26
- VSTM $306.32
- P/E Ratio
- ACNB $15.43
- VSTM N/A
- Revenue Growth
- ACNB 8.66
- VSTM N/A
- 52 Week Low
- ACNB $32.51
- VSTM $2.10
- 52 Week High
- ACNB $50.72
- VSTM $9.10
- Technical
- Relative Strength Index (RSI)
- ACNB 56.85
- VSTM 26.56
- Support Level
- ACNB $40.71
- VSTM $4.01
- Resistance Level
- ACNB $43.49
- VSTM $6.62
- Average True Range (ATR)
- ACNB 1.02
- VSTM 0.29
- MACD
- ACNB 0.20
- VSTM -0.11
- Stochastic Oscillator
- ACNB 80.54
- VSTM 9.17
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.